Literature DB >> 11338127

Distribution of HCV genotypes among risk groups in Serbia.

G Stamenkovic1, S Zerjav, Z M Velickovic, K Krtolica, V L Samardzija, L Jemuovic, D Nozic, B Dimitrijevic.   

Abstract

Blood samples from 190 patients that were anti-hepatitis C virus (HCV) positive were genotyped and 165 were found to contain HCV-RNA. Genotyping was performed by PCR based on type-specific primers (117 isolates) and LiPA test (48 isolates) and verifying by sequencing. In Serbia, the most frequent genotype was 1b (49.1%), followed by genotype 3 (21.2%) and genotype 1a (8.5%). The frequency of genotypes 2 and 4 was below 5% and mixed infections were encountered in 9.1% of cases. Distribution of genotypes was monitored in different risk groups: intravenous drug abusers, patients under blood transfusion, patients with previous history of surgery, patients undergoing hemodialysis and those with unknown risk factors. Genotype distribution is essentially the same in all the groups, except for the patients undergoing hemodialysis and those with previous history of surgery where significant difference exists compared with the group with unknown route of transmission (p < 0.001 and p < 0.05, respectively). There exists significant age-dependent genotype 3 distribution in Serbian population (p < 0.01).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11338127     DOI: 10.1023/a:1011060505152

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  36 in total

1.  Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.

Authors:  V Guadagnino; T Stroffolini; M Rapicetta; A Costantino; L A Kondili; F Menniti-Ippolito; B Caroleo; C Costa; G Griffo; L Loiacono; V Pisani; A Focà; M Piazza
Journal:  Hepatology       Date:  1997-10       Impact factor: 17.425

2.  Quantitative analysis of hepatitis C virus RNA in liver biopsies by competitive reverse transcription and polymerase chain reaction.

Authors:  G Grassi; G Pozzato; M Moretti; M Giacca
Journal:  J Hepatol       Date:  1995-10       Impact factor: 25.083

3.  cDNA sequencing of the 5' noncoding region (5' NCR) to determine hepatitis C genotypes in patients with chronic hepatitis C.

Authors:  C B O'Brien; B S Henzel; L Wolfe; K Gutekunst; D Moonka
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

Review 4.  Methods of transmission of hepatitis C.

Authors:  C J Tibbs
Journal:  J Viral Hepat       Date:  1995       Impact factor: 3.728

5.  Hepatitis C virus genotypes in different risk populations in Spain. The Hepatitis-HIV Spanish Study Group.

Authors:  R Bravo; V Soriano; J García-Samaniego; J González; A Castro; M Colmenero; E Carballo; A Mas; J González-Lahoz
Journal:  J Infect Dis       Date:  1996-02       Impact factor: 5.226

6.  Second-generation line probe assay for hepatitis C virus genotyping.

Authors:  L Stuyver; A Wyseur; W van Arnhem; F Hernandez; G Maertens
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

7.  Distribution of hepatitis C virus genotypes in Slovenia.

Authors:  K Seme; M Poljak; G Lesnicar; V Brinovec; S Stepec; S Koren
Journal:  Scand J Infect Dis       Date:  1997

8.  Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II.

Authors:  D Qu; J S Li; L Vitvitski; S Mechai; F Berby; S P Tong; F Bailly; Q S Wang; J L Martin; C Trépo
Journal:  J Hepatol       Date:  1994-07       Impact factor: 25.083

9.  Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region.

Authors:  F Davidson; P Simmonds; J C Ferguson; L M Jarvis; B C Dow; E A Follett; C R Seed; T Krusius; C Lin; G A Medgyesi
Journal:  J Gen Virol       Date:  1995-05       Impact factor: 3.891

10.  Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups.

Authors:  H Tokita; H Okamoto; P Luengrojanakul; K Vareesangthip; T Chainuvati; H Iizuka; F Tsuda; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1995-09       Impact factor: 3.891

View more
  5 in total

Review 1.  Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.

Authors:  Evan B Cunningham; Tanya L Applegate; Andrew R Lloyd; Gregory J Dore; Jason Grebely
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 46.802

2.  Hepatitis C virus genotypes in Serbia and Montenegro: the prevalence and clinical significance.

Authors:  Neda Svirtlih; Dragan Delic; Jasmina Simonovic; Djordje Jevtovic; Ljubisa Dokic; Eleonora Gvozdenovic; Ivan Boricic; Dragic Terzic; Sladjana Pavic; Gorana Neskovic; Sonja Zerjav; Vladimir Urban
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

3.  The "hidden" epidemic: a snapshot of Moroccan intravenous drug users.

Authors:  Roxana-Delia Trimbitas; Fatima Zahra Serghini; Fatiha Lazaar; Warda Baha; Abderrahim Foullous; Mohammed Essalhi; Abdelouahed El Malki; Abdelkrim Meziane Bellefquih; Abdelouaheb Bennani
Journal:  Virol J       Date:  2014-03-06       Impact factor: 4.099

4.  Molecular Assay and Genotyping of Hepatitis C Virus among Infected Egyptian and Saudi Arabian Patients.

Authors:  Mohamed Ms Farag; Ahmed R Sofy; Adel A Mousa; Mohamed A Ahmed; Mohamed R Alganzory
Journal:  Virology (Auckl)       Date:  2015-10-12

5.  Molecular characterization of HCV in a Swedish county over 8 years (2002-2009) reveals distinct transmission patterns.

Authors:  Josefine Ederth; Camilla Jern; Helené Norder; Lars Magnius; Erik Alm; Björg Kleverman Rognsvåg; Carl-Gustaf Sundin; Mia Brytting; Joakim Esbjörnsson; Mattias Mild
Journal:  Infect Ecol Epidemiol       Date:  2016-02-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.